#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3202	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2346	403.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1874	1874	T	493	T,C	416,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3202	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2346	403.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1608	1608	C	420	C	339	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	0	.	n	.	0	T695C	SNP	695	695	T	1180	1180	C	422	C	336	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	0	.	n	.	0	G1365A	SNP	1365	1365	G	1850	1850	A	398	A,C	334,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2456	2456	C	455	C	377	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2530	2530	A	470	A	382	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3082	3082	C	497	C	395	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5154	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3856	400.3	0	HET	.	.	.	C1005T	.	1005	1005	C	1490	1490	C	433	C,T	268,81	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	414	folP	855	855	100.0	folP.l15.c4.ctg.1	1902	65.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1163	1165	AGC	90;89;89	A,C;G;C,A	71,2;71;72,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1018	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3665	83.1	1	SNP	p	S91F	0	.	.	271	273	TCC	741	743	TCC	96;95;96	T;C;C	78;81;81	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1018	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3665	83.1	1	SNP	p	D95N	0	.	.	283	285	GAC	753	755	GAC	92;91;92	G;A,G;C	78;74,1;76	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1018	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3665	83.1	1	SNP	p	D95G	0	.	.	283	285	GAC	753	755	GAC	92;91;92	G;A,G;C	78;74,1;76	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	458	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1598	85.6	1	SNP	p	G45D	1	.	.	133	135	GAC	632	634	GAC	142;141;142	G;A,C;C	109;109,1;112	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	324	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1329	72.8	0	.	n	.	0	A197.	DEL	197	197	A	735	735	A	125	A	108	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1827	1829	GCA	94;94;96	G;C;A	83;82;83	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	0	.	p	.	0	F479L	NONSYN	1435	1437	TTT	1959	1961	CTT	108;107;107	C;T;T,G	84;84;82,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	1	SNP	p	D86N	0	.	.	256	258	GAC	780	782	GAC	78;77;80	G;A,T;C	59;57,1;63	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	1	SNP	p	S87W	0	.	.	259	261	AGT	783	785	AGT	80;81;81	A;G;T	61;66;65	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	1	SNP	p	S87R	0	.	.	259	261	AGT	783	785	AGT	80;81;81	A;G;T	61;66;65	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	1	SNP	p	S87I	0	.	.	259	261	AGT	783	785	AGT	80;81;81	A;G;T	61;66;65	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	848	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3359	75.7	1	SNP	p	S88P	0	.	.	262	264	TCC	786	788	TCC	81;81;82	T;C;C	63;63;62	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	842	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2883	87.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1669	1671	GGC	105;105;106	G;G;C	89;87;88	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1438	1440	GCA	106;106;106	G;C;A	84;84;85	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1441	1443	ATC	105;106;105	A;T;C	87;84;86	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1453	1455	GTG	103;103;103	G;T;G	85;81;85	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1453	1455	GTG	103;103;103	G;T;G	85;81;85	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1957	1959	ACC	84;84;83	A,C,G;C;C	65,1,1;70;69	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2011	2013	GCG	74;73;71	G;C;G	56;55;52	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2011	2013	GCG	74;73;71	G;C;G	56;55;52	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2134	2136	AGC	79;78;79	A,G;G,C;C	64,1;65,1;67	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2143	2145	GGC	80;80;80	G;G;C	66;69;66	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	742	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	80.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2161	2163	CCG	77;77;78	C;C;G	58;61;59	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1180	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3370	104.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1751	1753	CCG	110;110;110	C;C;G	87;90;90	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	446	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2228	60.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	810	810	C	64	C	52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1276	1278	AAT	2;2;2	A;A;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1279	1281	AAT	2;3;3	A;A;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1291	1293	GTT	3;3;3	G;T;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1303	1305	GCA	3;3;3	G;C;A	2;1;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1326	1328	GTA	3;3;3	G;T;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	66	porB1a	984	175	90.5	porB1a.l15.c4.ctg.1	1426	13.8	0	.	p	.	0	D238fs	FSHIFT	712	712	G	1338	1338	G	3	G	2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	849	851	AAG	159;157;157	A,T,C;A;G	122,1,1;124;130	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1125	1127	GAT	121;120;120	G;A;T	105;96;104	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1128	1130	GGT	120;119;119	G;G;T	103;104;102	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1134	1136	GCT	119;119;119	G;C;T	100;101;96	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1143	1145	ATG	117;117;118	A;T;G	101;103;101	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1260	1262	ACG	117;117;119	A;C;G,A	102;102;98,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1266	1268	GTT	119;119;119	G;T;T,C	98;97;100,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1380	1382	AAC	137;137;138	A;A;C	107;107;108	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	1	SNP	p	D121N	0	.	.	361	363	GAC	852	854	GAC	157;158;159	G,T;A;C	123,1;123;120	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	682	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	2032	100.5	1	SNP	p	A121D	1	.	.	361	363	GAC	852	854	GAC	157;158;159	G,T;A;C	123,1;123;120	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2038	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5190	117.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2139	2141	CAT	94;95;95	C,A;A;T	79,1;79;82	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	356	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1402	75.6	1	SNP	p	V57M	1	.	.	169	171	ATG	771	773	ATG	146;146;144	A;T;G	116;119;116	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
